Emergent Biosolutions
EBS
EBS
188 hedge funds and large institutions have $357M invested in Emergent Biosolutions in 2026 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 70 increasing their positions, 53 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.65% more ownership
Funds ownership: 82.65% → 83.3% (+0.65%)
33% less capital invested
Capital invested by funds: $537M → $357M (-$179M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
188
Holding in Top 10
1
Calls
$3.9M
Puts
$1.13M
Top Buyers
| 1 | +$6.62M | |
| 2 | +$5.3M | |
| 3 | +$5.23M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$3.72M |
| 5 |
Two Sigma Investments
New York
|
+$3.3M |
Top Sellers
| 1 | -$25.9M | |
| 2 | -$7.7M | |
| 3 | -$4.28M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.41M |
| 5 |
Jane Street
New York
|
-$2.88M |
